Form 4 for ARTV Artiva Biotherapeutics, Inc.
Accepted 2025-08-18 00:00:00 ET · period of report 2025-05-15 · accession 0001415889-25-022220 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-08-18 | 2025-05-15+ | ARTV | Horan Christopher | Chief Tech Ops Off | F - Tax | $2.58 | -4,918 | 83.7K | -6% | -$12.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-15 | F | D | 3,577 | $2.75 | 80,082 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards. |
| 2 | Common | Common Stock | 2025-05-15 | F | D | 1,341 | $2.13 | 83,659 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards. |